Direct answer

A stock perpetual normally gives the customer price exposure rather than ownership of the underlying share. In the EU, the operator may need to assess investment-services, derivatives, trading-venue, retail-distribution, market-data and conduct rules in addition to any MiCA analysis. The right route depends on the contract, reference asset, client segment, execution model and legal entities.

View related service: MiCA + MiFID II Authorisation

Key facts

No ownership

Price tracking is different

A perpetual generally does not give voting, dividend or shareholder rights.

Equity reference

Financial-instrument questions

The underlying and payoff can bring MiFID II analysis into focus.

Data rights

Not an afterthought

Index, exchange and benchmark permissions can affect launch feasibility.

At a glance

What the customer may actually receive
ModelCustomer positionMain first question
Real shareOwnership rightsHow is custody and execution authorised?
Tokenized securityA represented financial instrumentWhat rights and transfer restrictions attach?
Stock perpetualContractual price exposureWhich investment and product rules apply?

A practical sequence

  1. Name the reference

    Identify the share, index, benchmark or basket and its data source.

  2. Describe the payoff

    Explain leverage, margin, funding, liquidation, dividends and corporate actions.

  3. Segment the clients

    Map retail and professional distribution and the disclosures each receives.

  4. Model the venue

    Determine whether the operator is a CASP, investment firm, venue or a combination.

The market is asking for a familiar name

Calling something a stock perpetual makes it easy to understand and easy to misunderstand. The customer may see a familiar ticker, while the legal product is a derivative contract with no share ownership.

That gap belongs in the first product memo, not in a footnote after launch.

The calendar a mixed platform inherits

Two dates have already passed. MiCA's stablecoin rules applied from 30 June 2024, and the CASP title followed on 30 December 2024, so the spot side of a platform now operates inside the full regime, not a grace window. National grandfathering for previously registered CASPs ends 1 July 2026 at the latest, 18 months after the CASP title applied, and that deadline belongs to existing spot businesses rather than new product lines.

The derivatives side has no transition calendar at all. If a stock perpetual is offered to retail clients and classified as a CFD, the product-intervention limits ESMA agreed in 2018 under Decision (EU) 2018/796 show what can follow: retail leverage tiers from 30:1 down to 2:1 depending on the reference asset, a 50% margin close-out rule and negative balance protection. Those measures name CFDs, not perpetuals; whether a particular perpetual is legally a CFD is precisely what the classification work settles before launch.

A-share references add another layer

A product linked to an A-share price can raise questions about Chinese law, exchange data, benchmark use and intellectual property. EU permissions do not answer those questions by themselves.

A cross-border product team should treat the reference asset as a legal and data dependency, not just a marketing choice.

What a credible workplan looks like

The useful workplan joins legal classification to trading technology, data contracts, disclosures, risk controls and entity roles.

The result is more valuable than a generic promise of a single exchange licence because it identifies what can actually be launched.

Frequently asked questions

Does a stock perpetual give the customer a share?

Usually no; it generally creates price exposure under a contract.

Is MiCA irrelevant?

Not necessarily. Other spot or custody services can still be in scope.

Does an EU permission solve A-share data rights?

No. Data, benchmark, IP and Chinese-law questions may need separate work.

Do MiCA transition dates cover a new perpetual line?

No. The 1 July 2026 deadline protects certain existing spot CASPs; it is not a runway for launching derivatives.

Is this an investment recommendation?

No. It is a regulatory planning explanation.

Sources